Serum adiponectin and progression of diabetic nephropathy in patients with type 1 diabetes

被引:83
作者
Saraheimo, Markku [2 ]
Forsblom, Carol [2 ]
Thorn, Lena [2 ]
Waden, Johan [2 ]
Rosengard-Barlund, Milla [2 ]
Heikkilae, Outi [2 ]
Hietala, Kustaa
Gordin, Daniel [2 ]
Frystyk, Jan [3 ,4 ]
Flyvbjerg, Allan [2 ]
Groop, Per-Henrik [1 ,2 ]
机构
[1] Univ Helsinki, Folkhalsan Res Ctr, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Med, Div Nephrol, FIN-00014 Helsinki, Finland
[3] Aarhus Univ Hosp, Inst Clin, Med Dept Diabet & Endocrionol M, DK-8000 Aarhus, Denmark
[4] Aarhus Univ Hosp, Inst Clin, Med Res Labs, DK-8000 Aarhus, Denmark
关键词
D O I
10.2337/dc07-2306
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - The purpose of this study was to elucidate whether serum adiponectin is associated with progression of diabetic nephropathy in type 1 diabetic patients. RESEARCH DESIGN AND METHODS - This was a prospective follow-up study as a part of the nationwide Finnish Diabetic Nephropathy Study; 1,330 type 1 diabetic patients were followed for 5.0 +/- 2.2 years. Patients were divided at baseline into three groups according to their urinary albumin excretion rate (AER) in three consecutive overnight or 24-h urine collections: 818 patients with normoalbuminuria (AER <20 mu g/min), 216 patients with microalbuminuria (20 mu g/min <= AER < 200 mu g/min), and 296 patients with macroalbuminuria (AER >= 200 mu g/min). Progression of albuminuria was the main outcome. Adiponectin was measured by a time-resolved immunofluorometric assay, and the values were log-transformed and adjusted for age, BMI, and sex before analysis. RESULTS - Progression either to the next albuminuria level or to end-stage renal disease (ESRD) occurred in 193 patients. No difference in adiponectin concentrations was observed between progressors and nonprogressors in patients with normoalbuminuria or microalbuminuria. In the patients with macroalbuminuria, progression to ESRD was associated with higher adiponectin in the entire group (23.4 +/- 17.1 vs. 16.0 +/- 8.5 mg/l, P < 0.001) and in men (P < 0.001) and women (P < 0.001) separately. Progression to ESRD was also associated with systolic blood pressure, insulin dose, A1C, serum cholesterol, serum triglycerides, AER, and estimated glomerular filtration rate (eGFR). When these covariates were inserted in a Cox regression analysis; A1C, triglycerides, eGFR, and adiponectin were significantly associated with progression from macroalbuminuria. CONCLUSIONS - Increased serum adiponectin levels predict the progression from macroalbuminuria to ESRD in type 1 diabetic patients.
引用
收藏
页码:1165 / 1169
页数:5
相关论文
共 23 条
[1]   Renal insulin resistance syndrome, adiponectin and cardiovascular events in patients with kidney disease: The mild and moderate kidney disease study [J].
Becker, B ;
Kronenberg, F ;
Kielstein, JT ;
Haller, H ;
Morath, C ;
Ritz, E ;
Fliser, D .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :1091-1098
[2]   Plasma adiponectin concentration before and after successful kidney transplantation [J].
Chudek, J ;
Adamczak, M ;
Karkoszka, H ;
Budzinski, G ;
Ignacy, W ;
Funahashi, T ;
Matsuzawa, Y ;
Cierpka, L ;
Kokot, F ;
Wiecek, A .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (06) :2186-2189
[3]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[4]   Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms [J].
Fernandez, Marianella ;
Triplitt, Curtis ;
Wajcberg, Estela ;
Sriwijilkamol, Apiradee A. ;
Musi, Nicholas ;
Cusi, Kenneth ;
DeFronzo, Ralph ;
Cersosimo, Eugenio .
DIABETES CARE, 2008, 31 (01) :121-127
[5]   Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications [J].
Frystyk, J ;
Tarnow, L ;
Hansen, TK ;
Parving, HH ;
Flyvbjerg, A .
DIABETOLOGIA, 2005, 48 (09) :1911-1918
[6]   Possible relationship between adiponectin and renal tubular injury in diabetic nephropathy [J].
Fujita, Hlroki ;
Morii, Tsukasa ;
Koshimura, Jun ;
Ishikawa, Motoko ;
Kato, Masako ;
Miura, Takeshi ;
Sasaki, Hiroshi ;
Narita, Takuma ;
Ito, Seiki ;
Kakei, Masafumi .
ENDOCRINE JOURNAL, 2006, 53 (06) :745-752
[7]   Blockade of the renin-angiotensin system increases adiponectin concentrations in patients with essential hypertension [J].
Furuhashi, M ;
Ura, N ;
Higashiura, K ;
Murakami, H ;
Tanaka, M ;
Moniwa, N ;
Yoshida, D ;
Shimamoto, K .
HYPERTENSION, 2003, 42 (01) :76-81
[8]   Adiponectin: A novel adipokine linking adipocytes and vascular function [J].
Goldstein, BJ ;
Scalia, R .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2563-2568
[9]   Increased plasma adiponectin concentrations are associated with microangiopathy in type 1 diabetic subjects [J].
Hadjadj, S ;
Aubert, R ;
Fumeron, F ;
Pean, F ;
Tichet, J ;
Roussel, R ;
Marre, M .
DIABETOLOGIA, 2005, 48 (06) :1088-1092
[10]   Elevated serum concentration of adipose-derived factor, adiponectin, in patients with type 1 diabetes [J].
Imagawa, A ;
Funahashi, T ;
Nakamura, T ;
Moriwaki, M ;
Tanaka, S ;
Nishizawa, H ;
Sayama, K ;
Uno, S ;
Iwahashi, H ;
Yamagata, K ;
Miyagawa, JI ;
Matsuzawa, Y .
DIABETES CARE, 2002, 25 (09) :1665-1666